Cornerstone Pharmaceuticals

A Singular Focus on Cancer Metabolism

  • About
    • Overview
    • Leadership
    • Non-Executive Directors
    • Advisory Board Members
  • Cancer Metabolism
    • Overview
    • Our Approach
  • Platforms & Pipelines
    • Pipeline
    • AEMD/CPI-613
    • Emulsiphan/EmPAC
  • Clinical Trials
  • News & Media
    • Press Releases
    • News Coverage
    • Press Kit
    • Press Contacts
    • Scientific Papers and Abstracts
  • Careers
  • Contact
Home > News & Media > News CoveragePage 2

News Coverage

July 2009 The Doctor’s Channel Features Cornerstone Pharmaceuticals

« Previous
inner-5

Copyright 2012 © Cornerstone Pharmaceuticals, Inc. All Rights Reserved.Privacy Policy | Terms & Conditions

  • Home
  • About Us
    • Overview
    • Leadership
    • Non-Executive Directors
    • Advisory Board Members
  • Cancer Metabolism
    • Overview
    • Our Approach
  • Platforms & Pipelines
    • Pipeline
    • AEMD/CPI-613
    • Emulsiphan/EmPAC
  • Clinical Trials
  • News & Media
    • Press Releases
    • News Coverage
    • Press Kit
    • Press Contacts
    • Scientific Papers and Abstracts
  • Careers
  • Contact

Cornerstone Pharmaceuticals Using its profound and proprietary understanding of cancer metabolism,
Cornerstone is dedicated to revolutionizing the way cancer is treated.

Website Design by Jackrabbit Design

Follow us on Twitter